Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Matthew B. Klein
|
| gptkbp:collaboratedWith |
gptkb:Roche
gptkb:SMA_Foundation |
| gptkbp:developedBy |
gene therapies
small molecule drugs |
| gptkbp:focusesOn |
genetic disorders
rare diseases |
| gptkbp:foundedYear |
1998
|
| gptkbp:founder |
Stuart W. Peltz
|
| gptkbp:headquartersLocation |
gptkb:South_Plainfield,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
PTC Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Translarna
gptkb:Emflaza |
| gptkbp:numberOfEmployees |
over 1,000
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:regulates |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:researchInterest |
oncology
central nervous system disorders neuromuscular disorders |
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
PTCT
|
| gptkbp:website |
https://www.ptcbio.com/
|
| gptkbp:bfsParent |
gptkb:Evrysdi
|
| gptkbp:bfsLayer |
6
|